AEON Biopharma's total assets for Q1 2025 were $13.80M, an increase of 339.18% from the previous quarter. AEON total liabilities were $25.12M for the fiscal quarter, a -20.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.